Skip to content

Alan B. Sandler, Chief Development Officer at Revolution Medicines, sold RVMD on Sep 29, 2026

Data as of Oct 16

▼ SELL$203K1,000 shares at $202.81Alan B. Sandler Chief Development OfficerRVMD Revolution Medicines, Inc.
Watch RVMD
Traded
Sep 29, 2026
Disclosed
Oct 1, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Alan B. Sandler, Chief Development Officer at Revolution Medicines, sold RVMD on Sep 29, 2026TRADEDDISCLOSED
RVMDSimilar stocks (XLV — its sector index fund), rebased to RVMD's price on the disclosure day
RVMD since disclosure
−13.6%
after the sale
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund

Change in closing price from Oct 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAlan B. Sandler Chief Development OfficerRVMD Revolution Medicines, Inc.$244Kdisclosed Oct 1 · filed 2 days after the trade
  2. ▼ SELLAlan B. Sandler Chief Development OfficerRVMD Revolution Medicines, Inc.$61.6Kdisclosed Oct 1 · filed 2 days after the trade
  3. ▼ SELLAlan B. Sandler Chief Development OfficerRVMD Revolution Medicines, Inc.$442Kdisclosed Oct 1 · filed 2 days after the trade
  4. ▼ SELLAlan B. Sandler Chief Development OfficerRVMD Revolution Medicines, Inc.$325Kdisclosed Oct 1 · filed 2 days after the trade

See every trade on RVMD →